CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
58 hedge funds and large institutions have $39.6M invested in Carisma Therapeutics in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.55% less ownership
Funds ownership: 23.8% → 23.25% (-0.55%)
18% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 17
53% less capital invested
Capital invested by funds: $84M → $39.6M (-$44.4M)
Holders
58
Holding in Top 10
1
Calls
$2.45M
Puts
$786K
Top Buyers
| 1 | +$760K | |
| 2 | +$435K | |
| 3 | +$215K | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$66.8K |
| 5 |
SG Americas Securities
New York
|
+$58K |
Top Sellers
| 1 | -$1.79M | |
| 2 | -$153K | |
| 3 | -$130K | |
| 4 |
BlackRock
New York
|
-$124K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
-$92K |